P30 CA008748/GF/NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2019	1
2020	4
2022	5
2023	10
2024	4

1

Medical therapy for refractory pituitary adenomas.

Geer EB. Geer EB. Pituitary. 2023 Jun;26(3):303-306. doi: 10.1007/s11102-023-01320-9. Epub 2023 Apr 28. Pituitary. 2023. PMID: 37115295 Review.

2

MIB Guides: Preclinical Radiopharmaceutical Dosimetry.

Carter LM, Zanzonico PB. Carter LM, et al. Mol Imaging Biol. 2024 Feb;26(1):17-28. doi: 10.1007/s11307-023-01868-9. Epub 2023 Nov 14. Mol Imaging Biol. 2024. PMID: 37964036

3

Fifty years of progress in gastric cancer.

Coit DG, Strong VE. Coit DG, et al. J Surg Oncol. 2022 Oct;126(5):865-871. doi: 10.1002/jso.27060. J Surg Oncol. 2022. PMID: 36087088 Free PMC article.

4

Clinical and molecular characterization of primary sclerosing epithelioid fibrosarcoma of bone and review of the literature.

Tsuda Y, Dickson BC, Dry SM, Federman N, Suurmeijer AJH, Swanson D, Sung YS, Zhang L, Healey JH, Antonescu CR. Tsuda Y, et al. Genes Chromosomes Cancer. 2020 Apr;59(4):217-224. doi: 10.1002/gcc.22822. Epub 2019 Nov 15. Genes Chromosomes Cancer. 2020. PMID: 31675134 Free PMC article. Review.

5

Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1.

Mun SS, Meyerberg J, Peraro L, Korontsvit T, Gardner T, Malviya M, Kyi C, O'Cearbhaill RE, Liu C, Dao T, Scheinberg DA. Mun SS, et al. Cancer Immunol Immunother. 2023 Nov;72(11):3773-3786. doi: 10.1007/s00262-023-03529-w. Epub 2023 Aug 27. Cancer Immunol Immunother. 2023. PMID: 37635172 Free PMC article.

6

EZH2 inhibition: it's all about the context.

Rosen EY, Shukla NN, Glade Bender JL. Rosen EY, et al. J Natl Cancer Inst. 2023 Nov 8;115(11):1246-1248. doi: 10.1093/jnci/djad141. J Natl Cancer Inst. 2023. PMID: 37682251 No abstract available.

7

Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma.

Bhatia A, Moreno R, Reiner AS, Nandakumar S, Walch HS, Thomas TM, Nicklin PJ, Choi Y, Skakodub A, Malani R, Prabhakaran V, Tiwari P, Diaz M, Panageas KS, Mellinghoff IK, Bale TA, Young RJ. Bhatia A, et al. Clin Cancer Res. 2024 Jan 5;30(1):106-115. doi: 10.1158/1078-0432.CCR-23-1180. Clin Cancer Res. 2024. PMID: 37910594

8

Deep learning-based dominant index lesion segmentation for MR-guided radiation therapy of prostate cancer.

Simeth J, Jiang J, Nosov A, Wibmer A, Zelefsky M, Tyagi N, Veeraraghavan H. Simeth J, et al. Med Phys. 2023 Aug;50(8):4854-4870. doi: 10.1002/mp.16320. Epub 2023 Mar 13. Med Phys. 2023. PMID: 36856092

9

Assessment of Hypoxia in Breast Cancer: Emerging Functional MR Imaging and Spectroscopy Techniques and Clinical Applications.

Daimiel Naranjo I, Bhowmik A, Basukala D, Lo Gullo R, Mazaheri Y, Kapetas P, Eskreis-Winkler S, Pinker K, Thakur SB. Daimiel Naranjo I, et al. J Magn Reson Imaging. 2024 May 4. doi: 10.1002/jmri.29424. Online ahead of print. J Magn Reson Imaging. 2024. PMID: 38703143 Review.

10

The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma.

Sihag S, Nussenzweig SC, Walch HS, Hsu M, Tan KS, De La Torre S, Janjigian YY, Maron SB, Ku GY, Tang LH, Shah PM, Wu A, Jones DR, Solit DB, Schultz N, Ganesh K, Berger MF, Molena D. Sihag S, et al. Clin Cancer Res. 2022 Jun 13;28(12):2669-2678. doi: 10.1158/1078-0432.CCR-21-4016. Clin Cancer Res. 2022. PMID: 35377946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year